Investors

Date	Name	Title	Type	Shares Traded	Price Range
Apr 4, 2011	vagelos p roy	Officer	Disposition (Non Open Market)	4,954	n/a
Jan 8, 2013	vagelos p roy	Officer	Disposition (Non Open Market)	1,254	n/a
Apr 4, 2013	vagelos p roy	Officer	Disposition (Non Open Market)	1,215	n/a
May 6, 2013	van plew daniel p	Officer	Disposition (Non Open Market)	15,323	260.44
Oct 25, 2012	van plew daniel p	Officer	Disposition (Non Open Market)	16,043	159.55
Apr 27, 2012	van plew daniel p	Officer	Disposition (Non Open Market)	15,990	138.36
Feb 15, 2012	yancopoulos george	Officer	Disposition (Non Open Market)	67,017	109.29
May 6, 2013	yancopoulos george	Officer	Disposition (Non Open Market)	103,243	260.44
Dec 18, 2012	aberman michael s	Officer	Option Execute	1,200	24.00
Dec 10, 2012	aberman michael s	Officer	Option Execute	7,500	30.63
Nov 29, 2012	aberman michael s	Officer	Option Execute	8,334	24.00
Apr 30, 2012	aberman michael s	Officer	Option Execute	12,500	24.00
May 24, 2012	aberman michael s	Officer	Option Execute	500	24.00
Sep 2, 2011	aberman michael s	Officer	Option Execute	4,166	24.00
Sep 6, 2011	aberman michael s	Officer	Option Execute	8,334	24.00
May 13, 2013	aberman michael s	Officer	Option Execute	12,500	24.00
May 6, 2013	aberman michael s	Officer	Option Execute	8,334	24.00
Aug 10, 2011	baker charles a	Director	Option Execute	4,000	28.81
Apr 17, 2012	baker charles a	Director	Option Execute	2,090	18.80
Apr 19, 2012	baker charles a	Director	Option Execute	12,910	18.80
Showing 361-380 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.